ALPK2 and nonpapillary renal cell carcinoma: Analysis of 23 established ccRCC driver genes revealed selective enrichment in PT cells, while newly identified markers ITGB8 and ALPK2 demonstrated remarkable diagnostic potential, achieving 92% sensitivity and 95% specificity in distinguishing ccRCC from other kidney tumors.